A new law gives stores in Suffolk County, New York, 90 days to post warnings about the dangers of the liquid nicotine found in e-cigarettes.
Suffolk County Executive Steve Bellone signed the law on Monday. The new signs, which must be placed “in a conspicuous place at the register,” warn that liquid nicotine can be fatal and addictive. The move was spurred, in part, by the death of an 18-month-old child last year, and increased calls to poison control centers, according to Newsday. Continue reading
A potential health risk has prompted Amy’s Kitchen, Inc. to voluntarily recall over 73,000 cases of products containing organic spinach nationwide. According to a recall alert issued on March 25th, one of Amy’s organic spinach suppliers may have received organic spinach with the possible presence of Listeria monocytogenes.
In healthy individuals, this organism may only trigger short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Young children, frail, or elderly people, however, are at risk for serious and sometimes fatal infections. In pregnant women, listeria infections may result in miscarriages and still births. Continue reading
A recent court order indicates that 15 cases will be selected as eligible for potential inclusion in the Second Disposition Pool of the Mirena IUD multidistrict litigation (MDL). According to the order, the plaintiffs’ and the defendants’ parties will select five cases each and another five will be selected at random from a full list of filed lawsuits. Plaintiffs in the litigation allege that the contraceptive device caused serious injuries and that Bayer HealthCare Pharmaceuticals Inc. failed to warn about the risks. In particular, a number of lawsuits allege that the device migrated from its original position and perforated through the uterine wall. In some cases, the IUD has allegedly embedded itself in other parts of the body.
Parker Waichman LLP, a national personal injury law firm, represents a number of women in the Mirena IUD litigation. The firm has also had an active leadership role; Matthew J. McCauley, Senior Litigation Counsel at the firm, has been appointed Co-Lead Counsel in the MDL. Continue reading
A former part-time JCPenney employee has filed a lawsuit claiming retaliation after he reported the retailer was overcharging customers.
The fired employee has filed a claim against the company under Florida’s Private Whistleblower Act, Fortune reports. Former CEO Ron Johnson could be required to give a deposition. Continue reading
Medical device maker Zimmer, Inc. has initiated a voluntary recall of nearly 12,000 Persona Trabecular Metal Tibial knee replacement devices in response to increased complaints of loosening of the device.
The recall covers the Persona Trabecular Metal Tibial Plate/Persona TM Tibia-Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer, all lots land sizes, left and right. Research has shown that radiolucent lines (seen on x-rays), which show the gap between the cement and the device component, can be associated with early failure of the device. Some recipients have needed revision surgery to replace the defective component. Continue reading
Data from the U.S. Food and Drug Administration (FDA) shows that there are over 100,000 medical devices on the market. Unfortunately, not all of them are safe. In fact, agency data indicates that between 13 and 75 devices are recalled in the United States every day. Motley Fool reports that a regulatory loophole, which allows devices to be sold and implanted into patients without clinical testing, may be a major contributing factor to these statistics.
Manufacturers can submit certain devices for 510(k) approval; this process can allow a device to be sold on the market without clinical testing for safety or efficacy so long as the FDA finds that the product is “substantially equivalent” to an older product. Only Class I and Class II devices are eligible for 510(k) clearance. Class III “high-risk” devices must go through the more stringent premarket approval. Continue reading
A recent court order has directed the parties to select seven cases that may be included in the second Mirena intrauterine device (IUD) trial.
According to a court order filed on March 17, 2015, each side must select seven cases for potential inclusion in the Second Disposition Pool. The case is In Re: Mirena Litigation, Case No. 297 in the Superior Court of New Jersey Law Division: Bergen County. Raymond C. Silverman, partner at Parker Waichman LLP, has been appointed co-lead counsel in the litigation. Continue reading
Antipsychotic medications are sometimes used to treat aggressive or violent behavior in patients with dementia, but new research suggests that health care professionals should consider the risks closely before prescribing them. According to study published in JAMA Psychiatry, antipsychotic medications can increase the risk of early death in patients with dementia, including those with Alzheimer’s Disease. The U.S. Food and Drug Administration (FDA) already warns that antipsychotic drugs can have serious side effects in patients with dementia. The findings from this study support the practice of not using these drugs in dementia patients.
Using medical records from over 91,000 veterans over the age of 65, researchers from the University of Michigan’s Medical School and VA Center for Clinical Management Research compared mortality death rates between patients taking antipsychotic drugs for dementia to those who did not. The study found a 3.8 percent increased risk of death in patients taking haloperidol compared to those who did not take any antipsychotic medications. There was a 2.5 percent increased risk of death in patients taking olanzapine. Continue reading